Achilles Therapeutics (ACHL)
NASDAQ:ACHL

Achilles Therapeutics (ACHL) Stock Investors

113 Followers
Based on 748,394 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ACHL
On average, investors allocate 0.00% of their portfolios to ACHL
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,394 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ACHL

1.7%
Last 7
Days
5.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ACHL, out of 748,394 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ACHL Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,213 investors who made their portfolios public
The table shows changes in ACHL in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ACHL Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.54%
-1.72%
-5.58%
181.27M
Healthcare
DraftKings
5.77%
-1.15%
-1.80%
31.40B
Consumer Cyclical
Marathon Digital Holdings
5.54%
-1.09%
+0.30%
5.54B
Financial
UiPath
3.33%
-1.20%
-2.42%
6.99B
Technology
AMC Entertainment
5.74%
-1.22%
-4.08%
1.52B
Communication Services
Assertio Therapeutics
2.87%
-1.60%
-5.40%
139.83M
Healthcare
Airbnb
4.49%
-1.44%
+1.50%
90.19B
Consumer Cyclical
Merck & Company
3.91%
-0.38%
+3.17%
318.75B
Healthcare
ChargePoint Holdings
4.18%
-1.34%
-2.69%
863.37M
Consumer Cyclical
Celsius Holdings
4.44%
-0.09%
+2.14%
10.81B
Consumer Defensive
Based on the activity of 748,394 active portfolios
Open your Smart Portfolio

ACHL Investor Analysis

ACHL investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of ACHL holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
ACHL investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.7%
of ACHL holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
ACHL investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
48.1%
of ACHL holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of ACHL stock investors
See who invests in ACHL according to age group and performance.

FAQ

How many retail Investors hold ACHL?
<0.1% of TipRanks' retail investors hold ACHL in their portfolios.
    What is ACHL Investor Sentiment?
    ACHL’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ACHL in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of ACHL in the last 7 days.
        What percentage of retail investors changed their holding of ACHL in the last 30 days?
        ▼ 5.8% of TipRanks' retail investors changed their holding of ACHL in the last 30 days.
          What is the average age of retail investors who hold ACHL?
          The average age of ACHL Holders is over 55.
            What other stocks have ACHL investors also bought?
            ACHL Investors also bought CHRS, DKNG, MARA, PATH, AMC, ASRT, ABNB, MRK, CHPT, CELH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BAXBaxter International
              CRLCharles River Labs
              AVDLAvadel Pharmaceuticals
              HAEHaemonetics
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis